|
1
|
Intensity of renal support in critically ill patients with acute kidney injury.
|
N Engl J Med
|
2008
|
14.40
|
|
2
|
In-center hemodialysis six times per week versus three times per week.
|
N Engl J Med
|
2010
|
10.73
|
|
3
|
Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production.
|
Nat Med
|
2008
|
8.79
|
|
4
|
Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001.
|
J Am Soc Nephrol
|
2006
|
6.86
|
|
5
|
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.
|
Kidney Int
|
2011
|
4.27
|
|
6
|
Large-scale proteomics and phosphoproteomics of urinary exosomes.
|
J Am Soc Nephrol
|
2008
|
3.22
|
|
7
|
Acute kidney injury and chronic kidney disease as interconnected syndromes.
|
N Engl J Med
|
2014
|
3.08
|
|
8
|
Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin.
|
J Clin Invest
|
2005
|
2.75
|
|
9
|
Animal models of sepsis and sepsis-induced kidney injury.
|
J Clin Invest
|
2009
|
2.71
|
|
10
|
Reduced production of creatinine limits its use as marker of kidney injury in sepsis.
|
J Am Soc Nephrol
|
2009
|
2.61
|
|
11
|
Major contribution of tubular secretion to creatinine clearance in mice.
|
Kidney Int
|
2009
|
2.46
|
|
12
|
Discovery of protein biomarkers for renal diseases.
|
J Am Soc Nephrol
|
2004
|
2.43
|
|
13
|
Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome.
|
Kidney Int
|
2008
|
2.37
|
|
14
|
A simplified method for HPLC determination of creatinine in mouse serum.
|
Am J Physiol Renal Physiol
|
2004
|
2.17
|
|
15
|
Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice.
|
Kidney Int
|
2003
|
2.15
|
|
16
|
Kidney research national dialogue overview and commentary.
|
Clin J Am Soc Nephrol
|
2013
|
1.96
|
|
17
|
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology.
|
Clin J Am Soc Nephrol
|
2012
|
1.90
|
|
18
|
Urinary exosomal transcription factors, a new class of biomarkers for renal disease.
|
Kidney Int
|
2008
|
1.86
|
|
19
|
MRI of the basement membrane using charged nanoparticles as contrast agents.
|
Magn Reson Med
|
2008
|
1.77
|
|
20
|
Prospects for urinary proteomics: exosomes as a source of urinary biomarkers.
|
Nephrology (Carlton)
|
2005
|
1.77
|
|
21
|
Design of the VA/NIH Acute Renal Failure Trial Network (ATN) Study: intensive versus conventional renal support in acute renal failure.
|
Clin Trials
|
2005
|
1.75
|
|
22
|
Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator.
|
Am J Physiol Renal Physiol
|
2007
|
1.72
|
|
23
|
Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.
|
Bioconjug Chem
|
2003
|
1.67
|
|
24
|
Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice.
|
J Immunol
|
2012
|
1.61
|
|
25
|
Tamm-Horsfall protein and urinary exosome isolation.
|
Kidney Int
|
2010
|
1.61
|
|
26
|
Delayed DMSO administration protects the kidney from mercuric chloride-induced injury.
|
J Am Soc Nephrol
|
2004
|
1.60
|
|
27
|
Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury.
|
Am J Physiol Renal Physiol
|
2008
|
1.59
|
|
28
|
Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent.
|
J Natl Cancer Inst
|
2004
|
1.55
|
|
29
|
Liver proteomics for therapeutic drug discovery: inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failure.
|
Crit Care Med
|
2007
|
1.54
|
|
30
|
Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1.
|
Kidney Int
|
2011
|
1.52
|
|
31
|
Isolation and purification of exosomes in urine.
|
Methods Mol Biol
|
2010
|
1.44
|
|
32
|
Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent.
|
Cancer Res
|
2003
|
1.43
|
|
33
|
Peripheral CD4 T cells rapidly accumulate at the host: parasite interface during an inflammatory Th2 memory response.
|
J Immunol
|
2004
|
1.38
|
|
34
|
Newly developed techniques to study and diagnose acute renal failure.
|
J Am Soc Nephrol
|
2003
|
1.38
|
|
35
|
Alpha-melanocyte-stimulating hormone inhibits lung injury after renal ischemia/reperfusion.
|
Am J Respir Crit Care Med
|
2004
|
1.26
|
|
36
|
Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma.
|
Cancer Res
|
2006
|
1.26
|
|
37
|
Dendrimer-enhanced MRI as a diagnostic and prognostic biomarker of sepsis-induced acute renal failure in aged mice.
|
Kidney Int
|
2005
|
1.21
|
|
38
|
Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials.
|
Clin J Am Soc Nephrol
|
2012
|
1.20
|
|
39
|
A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity.
|
BMC Med
|
2007
|
1.19
|
|
40
|
Ischemic and nephrotoxic acute renal failure are distinguished by their broad transcriptomic responses.
|
Physiol Genomics
|
2006
|
1.19
|
|
41
|
Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography.
|
Magn Reson Med
|
2003
|
1.18
|
|
42
|
Methyl-2-acetamidoacrylate, an ethyl pyruvate analog, decreases sepsis-induced acute kidney injury in mice.
|
Am J Physiol Renal Physiol
|
2008
|
1.17
|
|
43
|
Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.
|
Kidney Int
|
2010
|
1.16
|
|
44
|
Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings.
|
Clin J Am Soc Nephrol
|
2012
|
1.13
|
|
45
|
Acute Kidney Injury Biomarkers - Needs, Present Status, and Future Promise.
|
Nephrol Self Assess Program
|
2006
|
1.11
|
|
46
|
Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury.
|
Kidney Int
|
2002
|
1.09
|
|
47
|
Detection of inflammation following renal ischemia by magnetic resonance imaging.
|
Kidney Int
|
2003
|
1.08
|
|
48
|
AKI: a path forward.
|
Clin J Am Soc Nephrol
|
2013
|
0.98
|
|
49
|
Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure.
|
J Magn Reson Imaging
|
2004
|
0.97
|
|
50
|
The Acute Dialysis Quality Initiative--part II: patient selection for CRRT.
|
Adv Ren Replace Ther
|
2002
|
0.97
|
|
51
|
Urinary exosomal Wilms' tumor-1 as a potential biomarker for podocyte injury.
|
Am J Physiol Renal Physiol
|
2013
|
0.95
|
|
52
|
Renal tubular damage detected by dynamic micro-MRI with a dendrimer-based magnetic resonance contrast agent.
|
Kidney Int
|
2002
|
0.94
|
|
53
|
Class B scavenger receptor types I and II and CD36 mediate bacterial recognition and proinflammatory signaling induced by Escherichia coli, lipopolysaccharide, and cytosolic chaperonin 60.
|
J Immunol
|
2011
|
0.92
|
|
54
|
Imaging acute renal failure with polyamine dendrimer-based MRI contrast agents.
|
Nephron Clin Pract
|
2006
|
0.92
|
|
55
|
alpha-Melanocyte-simulating hormone and interleukin-10 do not protect the kidney against mercuric chloride-induced injury.
|
Am J Physiol Renal Physiol
|
2002
|
0.92
|
|
56
|
Activated clearance of a biotinylated macromolecular MRI contrast agent from the blood pool using an avidin chase.
|
Bioconjug Chem
|
2003
|
0.90
|
|
57
|
Vasopressin: friend or foe?
|
Nat Med
|
2008
|
0.88
|
|
58
|
Designing clinical trials in acute kidney injury.
|
Clin J Am Soc Nephrol
|
2012
|
0.87
|
|
59
|
Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release.
|
Am J Respir Crit Care Med
|
2012
|
0.86
|
|
60
|
Micro-MRI methods to detect renal cysts in mice.
|
Kidney Int
|
2004
|
0.86
|
|
61
|
Database for renal collecting duct regulatory and transporter proteins.
|
Physiol Genomics
|
2003
|
0.85
|
|
62
|
Pulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice.
|
Stem Cells
|
2015
|
0.83
|
|
63
|
A comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA Consortium.
|
J Urol
|
2008
|
0.81
|
|
64
|
Frozen protein arrays: a new method for arraying and detecting recombinant and native tissue proteins.
|
Proteomics
|
2002
|
0.81
|
|
65
|
Improving CKD therapies and care: a National Dialogue.
|
Clin J Am Soc Nephrol
|
2014
|
0.80
|
|
66
|
Laser Capture Microdissection (LCM): Preparation and Sectioning of Frozen Tissue Blocks and Purification of RNA from Isolated Cells.
|
CSH Protoc
|
2006
|
0.77
|
|
67
|
cDNA synthesis and real-time PCR using RNA from laser-captured cells.
|
CSH Protoc
|
2006
|
0.77
|
|
68
|
Laser-capture microdissection.
|
Methods Mol Med
|
2003
|
0.77
|
|
69
|
Is there enough evidence to support use of N-acetylcysteine in contrast-induced nephropathy?
|
Ann Intern Med
|
2008
|
0.75
|
|
70
|
Frozen protein arrays.
|
Methods Mol Biol
|
2008
|
0.75
|